Chronic Respiratory Disease Questionnaire

Abstract

The Chronic Respiratory Disease Questionnaire (CRDQ) is a widely recognized, disease-specific psychometric instrument designed to measure the health-related Quality of Life (QoL) in patients suffering from chronic lung diseases. Initially developed to specifically gauge the impact of Chronic Obstructive Pulmonary Disease (COPD) on an individual’s daily functioning and emotional well-being, the CRDQ assesses several crucial domains affected by respiratory impairment.

Keywords

Chronic Respiratory Disease Questionnaire, CRDQ, Quality of Life, COPD, Chronic Lung Disease, Dyspnea, Respiratory Health, Health Measurement, Patient-Reported Outcome Measures.

Authors

Guyatt GH, et al. (1987); Dutch version: Wijkstra PJ, et al. (1994)

Purpose

The primary purpose of the CRDQ is to provide a standardized, sensitive, and reliable method for assessing the subjective experience of patients living with chronic respiratory conditions, particularly COPD. It is designed to be highly responsive to changes in clinical status and treatment effects, making it an invaluable tool in clinical trials and longitudinal observational studies.

The instrument focuses on quantifying the functional limitations and psychological distress associated with the disease, covering areas such as physical activities, general participation, and mental functions. By focusing on these specific areas, the CRDQ provides a more nuanced assessment of the disease burden than generic QoL instruments.

Construct

The CRDQ is structured to measure four distinct dimensions of Quality of Life relevant to chronic respiratory patients. These constructs capture the essential physical and emotional impact of the disease:

• Dyspnea: Measures the severity and frequency of breathlessness during various daily activities. This is often patient-specific, based on activities reported by the patient.
• Fatigue: Assesses the level of tiredness and lack of energy experienced by the patient, which is a common and debilitating symptom of lung disease.
• Emotional Function: Evaluates the psychological impact, including feelings of anxiety, frustration, depression, or fear related to their breathing difficulties.
• Mastery: Measures the patient’s sense of control over their condition and their ability to cope with their illness and its symptoms.

These four domains collectively address the impact on Activities, Mental functions, General participation, and Personal factors, aligning with the core functions identified in the original documentation.

Validity

The validity of the CRDQ has been extensively investigated across numerous international studies. Content validity is established through its focus on symptoms and functional limitations reported by patients with chronic lung disease. Construct validity is supported by demonstrating expected correlations with measures of lung function (e.g., FEV1), exercise capacity (e.g., six-minute walk test), and other established generic QoL scales.

Furthermore, the CRDQ exhibits strong known-groups validity, consistently demonstrating the ability to differentiate between patient groups defined by disease severity (mild vs. severe COPD) or clinical status (stable versus acutely exacerbated patients). Its sensitivity to change (responsiveness) is a key feature, confirming its utility in measuring clinically meaningful improvements or deteriorations over time.

Reliability

The CRDQ is recognized for its robust reliability. Internal consistency, typically measured using Cronbach’s alpha, is generally high (often exceeding 0.80) across all four domains, indicating that the items within each subscale reliably measure the same underlying construct. This consistency is maintained across various cultural adaptations, including the Dutch version.

Test-retest reliability is also strong when administered to clinically stable patients, demonstrating the instrument’s stability over short intervals. This indicates that variance in scores over time is likely due to genuine changes in the patient’s health status rather than measurement error inherent to the scale itself.

Factor Analysis

Confirmatory and exploratory factor analysis studies have consistently supported the hypothesized four-factor structure of the CRDQ. These analyses confirm that the items cluster into the distinct dimensions of Dyspnea, Fatigue, Emotional Function, and Mastery, reinforcing the theoretical foundation of the instrument.

While the four domains are distinct, they are moderately correlated, reflecting the interconnected nature of physical and emotional factors in chronic illness. Factor analysis has been crucial in validating the cross-cultural adaptations of the scale, ensuring that the underlying conceptual structure remains stable across different linguistic and cultural groups.

Instrument

Test Type: Disease-Specific Quality of Life Questionnaire

Format: Self-administered (Patient-Reported Outcome Measure, PROM) or interviewer-administered questionnaire, typically utilizing a 7-point Likert scale response format.

Language Available: English, Dutch (Wijkstra PJ, et al., 1994), and numerous other international translations.

Population Group: Adults, Elderly

Age Group: Typically utilized for adult populations (18 years and older), particularly those diagnosed with chronic lung diseases.

Population Details: Patients diagnosed with chronic respiratory conditions, including COPD, asthma, and other conditions affecting the circulatory and respiratory systems (Thorax/Abdomen/Organs).

Test Methodology: The scale requires patients to rate their experience of various symptoms and functions over a specified recall period (usually the preceding two weeks). The CRDQ generates a total score and four domain-specific subscores.

Keywords

Pulmonary Function, Responsiveness, Internal Consistency, Health Status, Chronic Illness, Patient Outcomes, Respiratory System.

Authors

Author ORCID Identifier: Not specified in source content.

Affiliation Email addresses: Not specified in source content.

Correspondence Address: Not specified in source content.

Permissions & Fee and Test Year

The original version of the CRDQ was published in 1987 by Guyatt GH, et al. The widely used Dutch adaptation was published in 1994. Information regarding current licensing fees and specific commercial permissions must be obtained directly from the original authors or copyright holders, as it is not detailed in the source.

Reference’s

Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42(10):773-778.

Wijkstra PJ, TenVergert EM, Van Altena R, et al. Reliability and validity of the Chronic Respiratory Questionnaire (CRQ) in a pulmonary rehabilitation setting. Thorax. 1994;49(5):448-450.

The original explanatory form (Toelichtingsformulier) for the instrument can be downloaded here: https://scales.arabpsychology.com/wp-content/uploads/instrumenten/CRQ-form.pdf

The original PDF of the measurement instrument (Meetinstrument) can be downloaded here: https://scales.arabpsychology.com/wp-content/uploads/instrumenten/CRQ-meetinstr.pdf

Items of the Chronic Respiratory (Disease) Questionnaire

IMPORTANT: The following scale items must be preserved in their original language and must not be changed in any way.

The specific items and scoring instructions for the Chronic Respiratory Disease Questionnaire were not provided directly in the source text, only links to the full instrument documentation.